CGTN
16.11.2020 10:11:09 CET | Business Wire | Press release
Two weeks after China unveiled a blueprint for its economic and social development for the next five years to 2025, Chinese leaders on Saturday laid out relatively specific plans and targets for the Yangtze River Economic Belt.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201116005494/en/
They included high-quality growth, green growth, opening-up as well as self-innovation.
These agendas were highlighted in a meeting in Nanjing, the capital city of Jiangsu Province, by Chinese President Xi Jinping, who just wrapped up inspection in the province.
Xi, also general secretary of the CPC Central Committee, went to Shanghai on November 12 to mark the 30th anniversary of Pudong's development and opening-up and later inspected Nantong and Yangzhou in Jiangsu.
This was Xi's first domestic inspection tour after the fifth plenary session of the 19th CPC Central Committee from October 26 to 29.
The key CPC meeting reviewed the 14th Five-Year Plan that takes high-quality growth as the goal for 2021-2025 and calls self-sufficiency in technology a strategic pillar for development.
It also said China will develop and urbanize regions, combine efforts to expand domestic demand with supply-side reform as well as widen its market to foreign capital.
Saturday's meeting decoded the grand development strategy for the first time for the vast region covering 11 provinces and municipalities.
At the meeting, Xi was briefed on the super-region's latest developments, and given advice and suggestions for future plans by four senior officials from the central government and chiefs from three provinces.
Xi said the super-region has made a remarkable contribution to China's recovery in the past months, pushing the country ahead of other major economies in pandemic recovery.
The plan to boost the Yangtze River Economic Belt must be consistent with the new development strategy, with an emphasis on a higher-quality growth, Xi said, adding it should be a role model for green growth, regional coordination, opening-up and self-innovation.
Xi said boosting the Yangtze River Economic Belt is of "strategic importance" as it covers 11 provinces and municipalities, from coastal regions Jiangsu and Shanghai to inland Sichuan and Chongqing.
Official data shows the super-region covers roughly one-fifth of China's land and has a population of 600 million, generating more than 40 percent of the country's GDP.
Environment vulnerability is the foremost concern for the sustainable growth of local economies along the river, Xi pointed out, asking officials to prioritize ecological restoration.
Stressing coordination, Xi said governments in the upper, middle and lower reaches of the river should overcome administrative barriers in restoring the ecology and improving mechanism monitoring, warning systems as well as disaster prevention and rescue procedures.
The Yangtze River Basin is now one of the most populated and developed regions in the world, but it also routinely suffers from flood in monsoon season.
This summer, the Yangtze River Basin saw the heaviest rainfall since 1961 and the worst flooding in decades.
According to the Ministry of Water Resources, some 219 people have died or gone missing in the floods and about 634.6 million people have been affected, causing economic losses of 178.96 billion yuan ($25.78 billion).
Speaking of the structural asymmetries of the Yangtze River Economic Belt, Xi said some labor-intensive companies can move their factories from coastal regions to inland areas, so as to stabilize domestic production and supply chain.
As the country's driving force, Xi said the super-region must build modernized industrial and supply chains that are more innovative, secure, reliable and valuable.
To reach the target, the region should invest more in innovation through setting up national and comprehensive innovative labs and giving more support to enterprises, he said.
He also renewed his pledge to open up market access, especially for inland regions, to foreign capital, and he asked officials to better integrate local economies into the Belt and Road Initiative so as to expand foreign investment and trade.
Chongqing and Chengdu, both along the Yangtze River Economic Belt, have already served as junctions of the Belt and Road Initiative.
They launched China-Europe freight train services in 2011 and 2013, respectively. Latest number showed that more than 10,000 freight trains had traveled between the two cities and Europe, accounting for over 40 percent of the total China-Europe train journeys.
Read the original article here .
View source version on businesswire.com: https://www.businesswire.com/news/home/20201116005494/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
